Form 8-K - Current report:
SEC Accession No. 0001493152-25-007703
Filing Date
2025-02-20
Accepted
2025-02-20 16:08:06
Documents
15
Period of Report
2025-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37923
2 ex10-1.htm EX-10.1 13361
  Complete submission text file 0001493152-25-007703.txt   266163

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rtgn-20250219.xsd EX-101.SCH 3272
4 XBRL DEFINITION FILE rtgn-20250219_def.xml EX-101.DEF 26198
5 XBRL LABEL FILE rtgn-20250219_lab.xml EX-101.LAB 35952
6 XBRL PRESENTATION FILE rtgn-20250219_pre.xml EX-101.PRE 24856
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4869
Mailing Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954
Business Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954 415-578-9583
RetinalGenix Technologies Inc. (Filer) CIK: 0001836295 (see all company filings)

EIN.: 823936890 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-258528 | Film No.: 25645365
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)